Guardant Health is overcoming skepticism with new cancer tests. Learn why GH stock is a buy, with strong growth and a shift ...

Guardant Health, Inc. (Nasdaq: GH), a leading precision oncology company, today announced the company will be participating ...

We recently compiled a list of the 12 Best Booming Stocks to Invest in Now. In this article, we are going to take a look at ...

Guardant Health, Inc. (Nasdaq: GH), a leading precision oncology company, today announced that on February 6, 2025, it ...

Inc. shares have reached a new 52-week high, touching $49.97 amidst a flurry of investor optimism. According to InvestingPro data, the company maintains a healthy financial position with a current ...

Guardant Health, Inc. (Nasdaq: GH), a leading precision oncology company, today announced it will report financial results for the fourth quarter and ...

Shares of Guardant Health (GH) have been struggling lately and have lost 6.7% over the past week. However, a hammer chart pattern was formed in its last trading session, which could mean that the ...

Craig-Hallum analyst William Bonello maintained a Buy rating on Guardant Health (GH – Research Report) today. The company’s shares closed ...

Guardant Health had a negative net margin of 74.02% and a negative return on equity of 1,200.44%. The company’s revenue for the quarter was up 33.9% compared to the same quarter last year.